Abstract
Proteins of the BCL2 family are key regulators of apoptosis. Their expression levels are frequently altered in cancers, enabling tumor cells to survive. To gain insight into the pathogenesis of hepatocellular carcinoma (HCC), we performed a comprehensive survey of the expression of the members of the BCL2 family in samples obtained from surgically resected HCCs. Here, we report the occurrence of a new molecular anomaly, consisting of a strong reduction in the expression of the proapoptotic protein BAD in HCC compared with surrounding nontumoral tissue. We investigate the function of BAD in a panel of HCC cell lines. Using gene overexpression and RNA interference, we show that BAD is involved in the cytotoxic effects of sorafenib, a multikinase blocker, which is currently the sole therapeutic drug effective for the treatment of HCC. Finally, we report that ABT-737, a compound that interacts with proteins of the BCL2 family and exhibits a BAD-like reactivity, sensitizes HCC cells toward sorafenib-induced apoptosis. Collectively, our findings indicate that BAD is a key regulator of apoptosis in HCC and an important determinant of HCC cell response to sorafenib.
References
Nov 15, 1996·Cell·J ZhaS J Korsmeyer
Nov 15, 1996·Cell·H G WangJ C Reed
Jan 27, 2000·Cell·D Hanahan, R A Weinberg
Jun 30, 2001·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·T TakeharaH Takahashi
Nov 15, 2002·Developmental Cell·Sandeep Robert DattaMichael E Greenberg
Aug 22, 2003·Nature·Nika N DanialStanley J Korsmeyer
May 20, 2005·Nature·Tilman OltersdorfSaul H Rosenberg
Oct 18, 2005·Cancer Cell·Qing-Bai SheNeal Rosen
May 16, 2006·Cancer Cell·Michael CertoAnthony Letai
Aug 16, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Ghassan K Abou-AlfaLeonard B Saltz
Dec 21, 2006·Cancer Research·Li LiuChristopher Carter
Apr 25, 2007·Apoptosis : an International Journal on Programmed Cell Death·Brian LeberDavid W Andrews
Jun 16, 2007·Gastroenterology·Hashem B El-Serag, K Lenhard Rudolph
Dec 22, 2007·Nature Reviews. Molecular Cell Biology·Richard J Youle, Andreas Strasser
Jan 19, 2008·Nature Reviews. Cancer·Anthony G Letai
Apr 12, 2008·Biochemical and Biophysical Research Communications·Jochen FuellerAntoine Galmiche
Jul 25, 2008·The New England Journal of Medicine·Josep M LlovetUNKNOWN SHARP Investigators Study Group
Oct 29, 2008·Oncogene·K W Yip, J C Reed
Nov 13, 2008·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Rajagopal N AravalliErik N K Cressman
Dec 24, 2008·Nature Reviews. Cancer·Jianming ZhangNathanael S Gray
Jan 22, 2009·Apoptosis : an International Journal on Programmed Cell Death·Anna FrenzelAndreas Villunger
Feb 6, 2009·World Journal of Gastroenterology : WJG·Isabel Fabregat
Apr 4, 2009·Nature Reviews. Cancer·Mark S CraggClare L Scott
May 2, 2009·Journal of the National Comprehensive Cancer Network : JNCCN·Ghassan K Abou-Alfa
Jul 31, 2009·Oncogene·T Ni Chonghaile, A Letai
Jul 31, 2009·Oncogene·N N Danial
Aug 28, 2009·Hepatology : Official Journal of the American Association for the Study of Liver Diseases·Yannick SimoninUrszula Hibner
Citations
Oct 2, 2013·European Journal of Medical Research·Tianran LiTianlong Huo
Jan 1, 2014·PloS One·Ingrid MarcqHicham Bouhlal
Jun 3, 2014·BMC Cancer·Rosalba D'AlessandroBrian I Carr
Dec 17, 2011·Biochemical and Biophysical Research Communications·Eric TrécherelAntoine Galmiche
Aug 18, 2012·Journal of Molecular Signaling·Vasileios A StamelosAlan Richardson
Jul 17, 2015·Scientific Reports·Jia WuJian-Ting Cai
Apr 20, 2012·International Journal of Cancer. Journal International Du Cancer·Zakaria EzzoukhryAntoine Galmiche
Mar 19, 2013·International Journal of Cancer. Journal International Du Cancer·Christophe LouandreAntoine Galmiche
May 26, 2012·Cancer Science·Xiaojia GuoCharles H Cha
Jun 20, 2015·BioMed Research International·Junsheng ChengYoucheng Zhang
Jan 2, 2014·Cancer Letters·Antoine GalmicheJean-Claude Barbare
Oct 29, 2011·Gynecologic Oncology·Hye Sook ChonJohnathan M Lancaster
Dec 3, 2014·Cancer Letters·Christophe LouandreAntoine Galmiche
May 29, 2016·Experimental Cell Research·Madhumathy G NairT S Sridhar
Jul 20, 2016·Cancer Letters·Hsiao-Hui LinAnn-Lii Cheng
Nov 2, 2016·Clinical Proteomics·Noriaki MorofujiTadashi Kondo
May 10, 2017·PloS One·Yoshinori OhnoYoichi Hiasa
Feb 7, 2020·Cancers·Blanca CucarullAlbert Morales
Apr 23, 2016·Oncotarget·Ming LiChundong Yu
Apr 24, 2018·Oncotarget·Anna TutusausAlbert Morales
Jan 30, 2020·Frontiers in Oncology·Huapeng ZhangShuijun Zhang
Mar 2, 2018·Oncotarget·Chloé SauzayAntoine Galmiche
Mar 12, 2011·Molecular Pharmacology·Zakaria EzzoukhryAntoine Galmiche
May 8, 2018·The Aging Male : the Official Journal of the International Society for the Study of the Aging Male·Norelia TorrealbaMar Royuela
Apr 4, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hetal BrahmbhattDavid W Andrews
May 6, 2021·Translational Oncology·Claire LaillerZuzana Saidak
May 21, 2021·The Journal of Pharmacy and Pharmacology·Davide GnocchiAntonio Mazzocca